UY29847A1 - N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos. - Google Patents
N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos.Info
- Publication number
- UY29847A1 UY29847A1 UY29847A UY29847A UY29847A1 UY 29847 A1 UY29847 A1 UY 29847A1 UY 29847 A UY29847 A UY 29847A UY 29847 A UY29847 A UY 29847A UY 29847 A1 UY29847 A1 UY 29847A1
- Authority
- UY
- Uruguay
- Prior art keywords
- cyclic
- processes
- bencensulphonamids
- tiadiazol
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas y a sus sales fisiológicamente aceptables y derivados fisiológicamente funcionales que muestran actividad agonista de PPARdelta o PPARdelta y PPARgamma. Se describen compuestos de fórmula I, en la que los radicales son como se han definido, y sus sales fisiológicamente aceptable, y procedimientos para sus preparaciones. Los compuetos son adecuados para el tratamiento y/o la prevención de trastornos del metabolismo de ácidos grasos y uso de la glucosa como también de trastornos en los que está implicada la resistencia a la insulina y otros trastornos desmielinizantes y neurodegenerativos de los sistemas nerviosos central y periférico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05021785 | 2005-10-06 | ||
PCT/EP2006/009299 WO2007039173A1 (en) | 2005-10-06 | 2006-09-26 | Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29847A1 true UY29847A1 (es) | 2007-05-31 |
Family
ID=45218083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29847A UY29847A1 (es) | 2005-10-06 | 2006-10-06 | N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7683181B2 (es) |
EP (1) | EP1937659B1 (es) |
JP (1) | JP2009510145A (es) |
KR (1) | KR20080050472A (es) |
CN (1) | CN101282952A (es) |
AR (1) | AR056562A1 (es) |
AT (1) | ATE487706T1 (es) |
AU (1) | AU2006299087A1 (es) |
BR (1) | BRPI0616886A2 (es) |
CA (1) | CA2624326A1 (es) |
DE (1) | DE602006018172D1 (es) |
IL (1) | IL190464A0 (es) |
MA (1) | MA29812B1 (es) |
NO (1) | NO20081675L (es) |
NZ (1) | NZ567205A (es) |
RU (1) | RU2008113208A (es) |
UY (1) | UY29847A1 (es) |
WO (1) | WO2007039173A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2207540B1 (en) | 2007-10-04 | 2014-02-26 | F. Hoffmann-La Roche AG | Cyclopropyl aryl amide derivatives and uses thereof |
KR20100101165A (ko) | 2007-12-26 | 2010-09-16 | 사노피-아벤티스 | 사이클릭 피리딜n(1,3,4)티아디아졸2일-벤젠 설폰아미드, 이들의 제조방법 및 약제로서의 이들의 용도 |
EP2291349A2 (en) | 2008-04-14 | 2011-03-09 | The Board of Regents of The University of Texas System | Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
US9045445B2 (en) | 2010-06-04 | 2015-06-02 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
CA2895162C (en) | 2012-12-14 | 2021-03-09 | D. Lynn Kirkpatrick | Methods and compositions for inhibiting cnksr1 |
CA2983260C (en) | 2015-04-20 | 2024-01-23 | Phusis Therapeutics, Inc. | Sulfonamide compounds, compositions and methods for inhibiting cnksr1 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL357678A1 (en) * | 2000-04-28 | 2004-07-26 | Sankyo Company, Limited | Ppargamma modulators |
-
2006
- 2006-09-26 CN CNA2006800370657A patent/CN101282952A/zh active Pending
- 2006-09-26 RU RU2008113208/04A patent/RU2008113208A/ru not_active Application Discontinuation
- 2006-09-26 NZ NZ567205A patent/NZ567205A/en not_active IP Right Cessation
- 2006-09-26 BR BRPI0616886-8A patent/BRPI0616886A2/pt not_active IP Right Cessation
- 2006-09-26 CA CA002624326A patent/CA2624326A1/en not_active Abandoned
- 2006-09-26 KR KR1020087008276A patent/KR20080050472A/ko not_active Application Discontinuation
- 2006-09-26 WO PCT/EP2006/009299 patent/WO2007039173A1/en active Application Filing
- 2006-09-26 EP EP06805858A patent/EP1937659B1/en active Active
- 2006-09-26 AU AU2006299087A patent/AU2006299087A1/en not_active Abandoned
- 2006-09-26 JP JP2008533905A patent/JP2009510145A/ja not_active Abandoned
- 2006-09-26 AT AT06805858T patent/ATE487706T1/de not_active IP Right Cessation
- 2006-09-26 DE DE602006018172T patent/DE602006018172D1/de active Active
- 2006-10-04 AR ARP060104360A patent/AR056562A1/es unknown
- 2006-10-06 UY UY29847A patent/UY29847A1/es not_active Application Discontinuation
-
2008
- 2008-03-26 IL IL190464A patent/IL190464A0/en unknown
- 2008-03-31 MA MA30790A patent/MA29812B1/fr unknown
- 2008-04-04 NO NO20081675A patent/NO20081675L/no not_active Application Discontinuation
- 2008-04-04 US US12/062,753 patent/US7683181B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
NZ567205A (en) | 2010-05-28 |
DE602006018172D1 (de) | 2010-12-23 |
JP2009510145A (ja) | 2009-03-12 |
KR20080050472A (ko) | 2008-06-05 |
US20080280959A1 (en) | 2008-11-13 |
EP1937659A1 (en) | 2008-07-02 |
CN101282952A (zh) | 2008-10-08 |
US7683181B2 (en) | 2010-03-23 |
CA2624326A1 (en) | 2007-04-12 |
BRPI0616886A2 (pt) | 2011-07-05 |
EP1937659B1 (en) | 2010-11-10 |
WO2007039173A1 (en) | 2007-04-12 |
RU2008113208A (ru) | 2009-10-10 |
NO20081675L (no) | 2008-04-23 |
IL190464A0 (en) | 2008-11-03 |
AU2006299087A1 (en) | 2007-04-12 |
MA29812B1 (fr) | 2008-09-01 |
AR056562A1 (es) | 2007-10-10 |
ATE487706T1 (de) | 2010-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2006000204A (es) | Derivados de fenil-[1,2,4]oxadiazol-5-ona con fenilo, procedimientos para su preparacion y su uso como productos farmaceuticos | |
ECSP099409A (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona, procedimientos para su preparación y su uso como agentes farmacéuticos | |
UY31873A (es) | Pirrolidin sulfonamidas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas | |
UY31872A (es) | Sulfonamidas n-heterocíclicas aneladas con grupo de cabeza de oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas | |
UY28837A1 (es) | Oxadiazolonas procedimientos para su preparación y su uso como productos farmacéuticos. | |
ECSP088322A (es) | Derivados de fenil-1,2,4-oxadiazolona, procesos para su preparación y su uso como compuestos farmacéuticos | |
UY28732A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparación y su uso como medicamentos. | |
UY29846A1 (es) | N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas, procesos para su preparación y su uso como productos farmacéuticos | |
MX2010006647A (es) | Piridil-n-[1,3,4]-tiadiazol-2-il-bencenosulfonamidas ciclicas, procedimientos para su preparacion y su uso como productos farmaceuticos. | |
UY29065A1 (es) | Derivados del ácido alcanoico arilcicloalquil-sustituidos, procedimientos para su preparación y su uso como productos farmacéuticos. | |
CL2007003263A1 (es) | Compuestos derivados de 1,4-benzotiepina 1,1-dioxido; producto farmaceutico; procedimiento de preparacion; y uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, e | |
UY28990A1 (es) | Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso. | |
UY32691A (es) | Compuestos de 1h-imidazo-[4,5-c]-quinolinona | |
CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
UY29847A1 (es) | N-(1,3,4)-tiadiazol-2-il-bencensulfonamidas cíclicas, procesos para su preparación y su uso como productos farmacéuticos. | |
DOP2015000005A (es) | Derivados de estra 1,3,5(10), 16 tetraeno 3 sustituidos, métodos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos | |
UY31874A (es) | Sulfonamidas con grupo de cabeza de heterociclo y oxadiazolona, procesos para su preparación y su uso como sustancias farmacéuticas | |
BRPI0606140A2 (pt) | tiazolidinonas, preparação e uso das mesmas como medicamento | |
GT200700097A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY29848A1 (es) | (1,3,4)-tiadiazol-2-il-amidas bicíclicas del ácido aril-sulfónico, procesos para su preparación y su uso como productos farmacéuticos | |
UY29308A1 (es) | Derivado de quinolina, su uso, preparación y medicamento que lo contiene | |
UY29832A1 (es) | Derivados de 2-aminotiazoles y 2-aminooxazoles, procesos para su preparación y su uso como compuestos farmacéuticos. | |
UY29849A1 (es) | 4-oxi-n-(1.3.4)-tiadiazol-2-il-bencenosulfonamidas, procesos para su preparación y su uso como productos farmacéuticos. | |
ECSP055984A (es) | Derivados cicloalquilo que tienen grupos ácido carboxílico bioisostéricos, procesos para su preparación y su uso como composiciones farmacéuticas | |
MX2007010841A (es) | 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20130128 |